|[August 28, 2014]
Exact Sciences to participate in Baird's 2014 Health Care Conference
MADISON, Wis. --(Business Wire)--
Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company
will participate in Baird's 2014 Health Care Conference in New York.
Kevin T. Conroy, the company's chairman and chief executive, will make
Exact's presentation at 9:05 a.m. ET on Thursday, Sept. 4.
A live webcast of the presentation will be available through the
company's website at www.exactsciences.com.
An archived webcast will be available following the conclusion of the
About Exact Sciences Corp.
Exact Sciences Corp. is a molecular diagnostics company focused on the
early detection and prevention of colorectal cancer. The company has
exclusive intellectual property protecting its noninvasive, molecular
screening technology for the detection of colorectal cancer. Stool-based
DNA technology is included in the colorectal cancer screening guidelines
of the American Cancer Society and the U.S. Multi-Society Task Force on
Colorectal Cancer. For more information, please visit the company's
webite at www.exactsciences.com.
Certain statements made in this news release contain forward-looking
statements within the meaning of Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities and Exchange Act of
1934, as amended that are intended to be covered by the "safe harbor"
created by those sections. Forward-looking statements, which are based
on certain assumptions and describe our future plans, strategies and
expectations, can generally be identified by the use of forward-looking
terms such as "believe," "expect," "may," "will," "should," "could,"
"seek," "intend," "plan," "estimate," "anticipate" or other comparable
terms. Forward-looking statements in this news release may address the
following subjects among others: statements regarding the sufficiency of
our capital resources, our ability to secure favorable reimbursement
rates from Medicare and other third-party payors, timing of our launch
of a commercial product, our estimates of the available market size and
our potential penetration, expected research and development expenses,
expected general and administrative expenses and our expectations
concerning our business strategy. Forward-looking statements involve
inherent risks and uncertainties which could cause actual results to
differ materially from those in the forward-looking statements, as a
result of various factors including those risks and uncertainties
described in the Risk Factors and in Management's Discussion and
Analysis of Financial Condition and Results of Operations sections of
our most recently filed Annual Report on Form 10-K and our subsequently
filed Quarterly Reports on Form 10-Q. We urge you to consider those
risks and uncertainties in evaluating our forward-looking statements. We
caution readers not to place undue reliance upon any such
forward-looking statements, which speak only as of the date made. Except
as otherwise required by the federal securities laws, we disclaim any
obligation or undertaking to publicly release any updates or revisions
to any forward-looking statement contained herein (or elsewhere) to
reflect any change in our expectations with regard thereto or any change
in events, conditions or circumstances on which any such statement is
[ Back To TMCnet.com's Homepage ]